Aptose Biosciences (FRA:LTI0) YoY EPS Growth : 88.08% (As of Mar. 2025)

View and export this data going back to 2014. Start your Free Trial

What is Aptose Biosciences YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Aptose Biosciences's YoY EPS Growth for the quarter that ended in Mar. 2025 was 88.08%.

Aptose Biosciences's Earnings per Share (Diluted) for the three months ended in Mar. 2025 was €-2.41.

Aptose Biosciences YoY EPS Growth Historical Data

The historical data trend for Aptose Biosciences's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptose Biosciences YoY EPS Growth Chart

Aptose Biosciences Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EPS Growth

Get a 7-Day Free Trial

-17.68

-17.31

33.76

-8.30

83.34

Aptose Biosciences Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
YoY EPS Growth	Get a 7-Day Free Trial															67.43	80.93	79.79	98.10	88.08

Aptose Biosciences YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Aptose Biosciences's YoY EPS Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EPS Growth (A: Dec. 2024 )
=	(Earnings per Share (Diluted) (A: Dec. 2024 )	-	Earnings per Share (Diluted) (A: Dec. 2023 ))	/	\| Earnings per Share (Diluted) (A: Dec. 2023 ) \|
=	(-34.743	-	-208.553)	/	\| -208.553 \|
=	83.34 %

Aptose Biosciences's YoY EPS Growth for the quarter that ended in Mar. 2025 is calculated as:

	YoY EPS Growth (Q: Mar. 2025 )
=	(Earnings per Share (Diluted) (Q: Mar. 2025 )	-	Earnings per Share (Diluted) (Q: Mar. 2024 ))	/	\| Earnings per Share (Diluted) (Q: Mar. 2024 )) \|
=	(-2.414	-	-20.258)	/	\| -20.258 \|
=	88.08 %

Aptose Biosciences YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Aptose Biosciences's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Aptose Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptose Biosciences Inc (FRA:LTI0) » Definitions » YoY EPS Growth

Comparable Companies

Traded in Other Exchanges

APTOF:USA 0UI8:UK APS:Canada

Address

66 Wellington Street West, Suite 5300, TD Bank Tower Box 48, Toronto, ON, CAN, M5K 1E6

Website

https://www.aptose.com

Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.

Aptose Biosciences Headlines

No Headlines